Shuren Steps Down, FDA’s Reimbursement Work, and Global Updates
In this week’s Pathways Picks: CDRH’s long-time director Jeff Shuren announces his retirement; FDA digs deeper on reimbursement; FDA funding bill slows; China publishes new procedures for importing urgent-use, unapproved devices; El Salvador moves forward on super agency; and more global medtech policy updates.
Read Article